Interleukin ‐17A biomarker as a predictor for detection of early axial spondyloarthritis changes in patients with psoriasis

ConclusionOur study can imply that IL ‐17A is a valuable, useful and low‐cost biomarker in detecting early axial SpA changes in asymptomatic and nonradiographic axial SpA (nr‐axial SpA) psoriatic patients that helps early management and prevent progressive axial involvement and disabilities.

Source: International Journal of Rheumatic Diseases - October 4, 2020 Category: Rheumatology Authors: Dalia S. Saif, Mohamed A. El Tabl, Naglaa Afifi, Mahmoud S. Abdallah, Sally M. El Hefnawy, Shimaa A. Hassanein Tags: ORIGINAL ARTICLE Source Type: research